* Q1 exceeded our expectations, but limited estimate revisions * Confirms that Q4 was likely the ser...
* Multi-year contracts of MSEK 300 announced in April * Lower product sales in Q1 * We adjust our fa...
* Q1 sales SEK 13m, adj. EBIT SEK -16m (vs. ABGSCe 8m & -12m) * Softer quarter; no machine deliverie...
Today, LIMES announced that its supervisory board has approved the FY25 annual accounts, confirming ...
Redeye retains its positive view of Addnode despite a relativley soft Q1 report.
* Q1 EBITDA of DKK -1.2m above ABG DKK -3.2m * FY'26 guidance unchanged * Expect mid-single-digit po...
Bet-at-home recently published its final FY25 figures.
* 2026 now also clouded by uncertainty * '26e-'27e EBIT down 12-4%; ~60% EBIT CAGR '25-'28e * 20-11x...
* +9% organic growth y-o-y, +1% vs. ABGSCe * 19% adj.
Revenue amounted to EUR 65.7m and was 2% below our estimate.
Solteq reported a weak Q1, with both revenue and earnings below estimates.
YIT’s Q1 results were well in line with expectations on an operative level, although one-offs clearl...
We hosted tonies at our Madrid conference. The key takeways fully underpin our positive view on the ...
* Q1 sales 11% lower than ABGSCe SEK 43m * Improved gross profit, likely due to favourable mix * Lik...
Redeye updates its view on Hacksaw following stronger-than-expected Q1 results, driven by operationa...
* Sales +4% and adj. EBITA -26% vs. consensus * Consensus EBITA estimates likely down by high single...
* EEs +7%, sales +8%, adj. EBIT +53% vs. ABGSCe * Stronger EBIT driven by series production and mild...
* Sales SEK 12.7m (vs. ABGSCe 7.8m), positive one-off effect of 4.
Redeye’s initial take on Sleeps Cycles' Q1 report confirms the company remains on track with its 202...
Gofore reported continued good sales momentum in March and the Q1 organic sales growth improved to 2...